Facebook
Twitter
Telegram
Report an ErrorAlexion Pharmaceuticals, Inc. Financial Ratios 2011-2024 | ALXN
Annual Financial Ratios Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
55.7 | 9.3 | 348.2 | 61.8 | 71.9 | 215.7 | 55.3 | 125.3 | 71.3 | 78.4 |
P/S |
5.5 | 4.5 | 6.5 | 7.7 | 9.3 | 12.0 | 16.3 | 20.4 | 16.0 | 17.5 |
EV/EBITDA |
10.7 | 9.1 | 14.9 | 26.4 | 27.6 | 42.0 | 36.8 | 55.1 | 38.2 | 54.0 |
PEG |
-0.75 | 0.0 | -4.23 | 5.5 | 0.44 | -2.71 | 0.35 | -33.57 | 1.8 | 1.03 |
P/B |
2.9 | 2.0 | 2.9 | 3.1 | 3.3 | 3.8 | 11.0 | 13.3 | 9.2 | 12.1 |
P/CF |
11.6 | 11.7 | 126.8 | 36.1 | 38.1 | 80.1 | 72.1 | 67.7 | 46.7 | 55.4 |
ROE % |
5.18 | 21.33 | 0.85 | 4.98 | 4.59 | 1.75 | 19.89 | 10.62 | 12.93 | 15.45 |
ROA % |
3.33 | 13.70 | 0.56 | 3.26 | 3.01 | 1.10 | 15.63 | 7.62 | 9.75 | 12.57 |
ROCE % |
17.36 | 13.09 | 12.50 | 6.37 | 6.38 | 5.50 | 25.47 | 20.71 | 20.12 | 20.98 |
DSO |
84.7 | 90.9 | 81.5 | 74.7 | 76.9 | 74.7 | 70.7 | 99.2 | 95.1 | 113.8 |
DIO |
511.5 | 580.7 | 460.8 | 370.0 | 530.5 | 453.9 | 370.4 | 210.9 | 473.7 | 318.9 |
DPO |
78.2 | 68.5 | 72.6 | 56.9 | 90.5 | 89.8 | 92.4 | 44.4 | 107.7 | 62.8 |
All numbers in USD currency